Virtually all Down syndrome (DS) adults develop progressive neurodegeneration as seen in Alzheimer's disease (AD), and overexpression of the amyloid precursor protein (APP), a gene located on chromosome 21, is thought to contribute to AD in DS [1]–[3]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.